Globus Medical (GMED)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) metric for Globus Medical has been provided for various quarters spanning from March 31, 2020, to December 31, 2024. However, the specific DSO values are indicated as "-- days" for each period, suggesting that the exact DSO figures are not available in the provided data.
DSO is a financial ratio that indicates the average number of days a company takes to collect revenue after a sale is made. A lower DSO value typically signifies more efficient accounts receivable management, while a higher DSO could indicate potential issues with collections or credit terms.
In the absence of concrete DSO data for Globus Medical across the specified time frame, a detailed analysis of the trend, comparison with industry peers or historical performance, and potential implications for the company's cash flow and working capital management cannot be provided. Additional information or specific DSO values would be required to conduct a more in-depth assessment of Globus Medical's performance in terms of accounts receivable management.
Peer comparison
Dec 31, 2024